PARIS: SubjectWell, a platform that connects patients with chronic conditions to new treatments, has announced that it has acquired PatientCentra, a division of MD Connect, Inc.
PatientCentra is a global provider of patient recruitment services, with a focus on developing patient-centric programs. By acquiring PatientCentra, SubjectWell can now recruit patients for all international clinical trials, and enhance its capabilities for rare diseases and oncology studies.
“We listened to our global customers who wanted us to help them with large cross-border studies,” said Fred Martin, CEO of SubjectWell. “PatientCentra has a proven track record of delivering digital patient recruitment solutions in five continents. Together with SubjectWell’s unparalleled access to motivated patients with known diseases in North America, we are increasing our ability to support life-changing research worldwide.”
“We are excited to join SubjectWell,” said Dan Stempel, founder and CEO of PatientCentra. “We see a great opportunity to offer our tailored clinical recruitment solutions, such as multi-channel outreach, patient websites, and concierge support, to SubjectWell’s large customer base. Our shared customers can now trust one company to fully assist them in recruiting patients for vaccines, chronic diseases, rare diseases, and oncology trials.”